Related Experiment Video
Updated: Jun 13, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
The role for osmotic agents in children with acute encephalopathies: a systematic review
Samson Gwer1, Hellen Gatakaa, Leah Mwai
1Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Collaborative Research Programme, Kilifi, Kenya. sgwer@kilifi.kemri-wellcome.org
Insights
Hypertonic saline effectively reduces intracranial pressure in children with acute encephalopathy, outperforming mannitol. Oral glycerol also shows promise in improving outcomes for bacterial meningitis cases.
Area of Science:
- Pediatric Neurology
- Critical Care Medicine
- Pharmacology
Background:
- Raised intracranial pressure (ICP) is a critical complication in acute encephalopathies, impacting cerebral perfusion and potentially leading to fatal outcomes.
- Current guidelines for managing ICP in children often rely on adult data, highlighting a need for pediatric-specific evidence.
- Osmotic agents are a cornerstone of ICP management, but their efficacy and safety in pediatric populations require thorough evaluation.
Purpose of the Study:
- To review the existing evidence on the effectiveness of osmotic agents in reducing ICP in children with acute encephalopathy.
- To assess the impact of osmotic agents on coma resolution, neurological sequelae, and mortality in pediatric patients.
- To compare the efficacy of different osmotic agents, including hypertonic saline and glycerol, in the pediatric population.
Main Methods:
- A comprehensive literature search was conducted across multiple databases for studies published between January 1966 and March 2009.
- Included studies focused on children aged 0-16 years with acute encephalopathies treated with osmotic agents.
- Outcomes assessed included reduction in ICP, time to coma resolution, neurological sequelae, and mortality.
Main Results:
- Hypertonic saline (HS) demonstrated superior and more sustained reduction in ICP compared to mannitol and other fluids, especially when administered via continuous infusion.
- Bolus administration of glycerol and mannitol provided transient ICP reduction.
- Oral glycerol was linked to reduced mortality and neurological sequelae in children with acute bacterial meningitis, while HS showed lower mortality than mannitol in non-traumatic encephalopathies.
Conclusions:
- Hypertonic saline appears to be more effective in reducing ICP in children than other osmotic agents.
- Oral glycerol may improve outcomes in pediatric acute bacterial meningitis.
- Further research is needed to optimize the administration of osmotic agents for sustained ICP reduction in children.
Background:
Raised intracranial pressure (ICP) is known to complicate both traumatic and non-traumatic encephalopathies. It impairs cerebral perfusion and may cause death due to global ischaemia and intracranial herniation. Osmotic agents are widely used to control ICP. In children, guidelines for their use are mainly guided by adult studies. We conducted this review to determine the current evidence of the effectiveness of osmotic agents and their effect on resolution of coma and outcome in children with acute encephalopathy.
Methods:
We searched several databases for published and unpublished studies in English and French languages, between January 1966 and March 2009. We considered studies on the use of osmotic agents in children aged between 0 and 16 years with acute encephalopathies. We examined reduction in intracranial pressure, time to resolution of coma, and occurrence of neurological sequelae and death.
Results:
We identified four randomized controlled trials, three prospective studies, two retrospective studies and one case report. Hypertonic saline (HS) achieved greater reduction in intracranial pressure (ICP) compared to mannitol and other fluids; normal saline or ringer's lactate. This effect was sustained for longer when it was given as continuous infusion. Boluses of glycerol and mannitol achieved transient reduction in ICP. Oral glycerol was associated with lower mortality and neurological sequelae when compared to placebo in children with acute bacterial meningitis. HS was associated with lower mortality when compared to mannitol in children with non-traumatic encephalopathies.
Conclusion:
HS appears to achieve a greater reduction in ICP than other osmotic agents. Oral glycerol seems to improve outcome among children with acute bacterial meningitis. A sustained reduction in ICP is desirable and could be achieved by modifying the modes and rates of administration of these osmotic agents, but these factors need further investigation.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
Cerebral Edema l: Introduction
Pharmaceutical Poisoning: Treatment Strategies
Hepatic Encephalopathy
Encephalitis ll: Pathophysiology
